The MS Society of Canada is pleased to announce the launch of a new research funding competition – the Contract Research Organization (CRO) Grant. The CRO Grant will enable principal investigators to apply for funding to pay for specific research services offered by CROs and specialized drug discovery and development organizations, with the aim of advancing research and development of treatments for progressive MS.
CROs have emerged as valuable partners in drug development, as they possess the expertise and infrastructure to conduct scientific experiments that test, validate and de-risk early stage drug discoveries. CROs offer a range of services that reduce time and costs associated with drug discovery research. In addition, they offer a high standard of quality which diminishes the chances of error and eliminates the need for hiring and training research staff.
For details please review the Request for Applications.